We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Isis and Alnylam Issued U.S. Patent Broadly Covering Chemical Modifications of Oligonucleotide Therapeutics

News   Dec 05, 2006

 
Isis and Alnylam Issued U.S. Patent Broadly Covering Chemical Modifications of Oligonucleotide Therapeutics
 
 
 

RELATED ARTICLES

Are Transplanted Stem Cells Healing the Target Organ? Perhaps Ask the Exosomes

News

While many regenerative medicine applications are being pursued, the ability to track cells after transplant and determine their therapeutic efficacy is a challenge. Could exosomes, circulating cell-derived vesicles, hold the key?

READ MORE

Discovery of Novel Genes May Lead to New Therapies for Muscle Cancer

News

Scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.

READ MORE

Why Not Catching Enough Zzz’s Is Bad for Your Heart

News

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE